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Huntington’s disease (HD) is caused by expansion of the polymorphic polyglutamine segment in the hunting-
tin protein. Full-length huntingtin is thought to be a predominant HEAT repeat a-solenoid, implying a role as a
facilitator of macromolecular complexes. Here we have investigated huntingtin’s domain structure and poten-
tial intersection with epigenetic silencer polycomb repressive complex 2 (PRC2), suggested by shared
embryonic deﬁciency phenotypes. Analysis of a set of full-length recombinant huntingtins, with different
polyglutamine regions, demonstrated dramatic conformational ﬂexibility, with an accessible hinge separ-
ating two large a-helical domains. Moreover, embryos lacking huntingtin exhibited impaired PRC2 regulation
of Hox gene expression, trophoblast giant cell differentiation, paternal X chromosome inactivation and his-
tone H3K27 tri-methylation, while full-length endogenous nuclear huntingtin in wild-type embryoid bodies
(EBs) was associated with PRC2 subunits and was detected with trimethylated histone H3K27 at Hoxb9.
Supporting a direct stimulatory role, full-length recombinant huntingtin signiﬁcantly increased the histone
H3K27 tri-methylase activity of reconstituted PRC2 in vitro, and structure–function analysis demonstrated
that the polyglutamine region augmented full-length huntingtin PRC2 stimulation, both in Hdh
Q111 EBs and
in vitro, with reconstituted PRC2. Knowledge of full-length huntingtin’s a-helical organization and role as a
facilitator of the multi-subunit PRC2 complex provides a novel starting point for studying PRC2 regulation,
implicates this chromatin repressive complex in a neurodegenerative disorder and sets the stage for further
study of huntingtin’s molecular function and the impact of its modulatory polyglutamine region.
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In 1993, genetic studies identiﬁed the CAG trinucleotide repeat
mutation that causes Huntington’s disease (HD) (1). This dom-
inantly inherited disorder is characterized by loss of brain
neurons, especially in the striatum, and the inexorable onset of
motor, cognitive and behavioral symptoms (2). The HD
mutation comprises expanded versions of a polymorphic CAG
repeat that elongate a variable polyglutamine segment in the
huntingtin protein, from the normal range (8–37 residues) to
38 or more residues (1). This polymorphic polyglutamine
segment is thought to confer a subtle structural alteration and
gain of huntingtin function (3,4). Indeed, genotype–phenotype
studies have demonstrated that the polyglutamine region nor-
mally modulates huntingtin function in cellular energy metab-
olism (3,5,6) and the expression of expanded polyglutamine
tracts within the endogenous huntingtin protein is associated
with dominant phenotypes in model systems (7,8). However,
while polyglutamine, alone or embedded in short polypeptides,
exhibits striking physical properties (9,10), typically measured
in aggregation assays (11), little is known of the molecular
impactofthepolyglutamineregiononthestructureandfunction
of the full-length huntingtin protein, though this information is
needed to fully understand huntingtin biology and the trigger
of HD pathogenesis.
Full-length huntingtin is now thought to comprise a large
a-helical solenoid (repeated units arranged in a continuous
superhelix/coil) (12) rather than a globular protein, as its
3144 amino acid length was predicted to be entirely
spanned by loosely conserved HEAT/HEAT-like repeats
(13). Indeed HEAT repeats, curling anti-parallel a-helical
units, were ﬁrst recognized within huntingtin (14) and were
named for huntingtin and for elongation factor 3 component
eIF3k, protein phosphatase 2A regulatory subunit PR65/A
and target of rapamycin TOR1 (14), though this structural
element now deﬁnes a larger class of proteins (15). HEAT
and HEAT-like repeats may augment other motifs (e.g.
eIF3k and TOR1) or may encompass the entire protein (e.g.
PR65/A and importin-b), stacking to confer dramatic confor-
mational ﬂexibility and multi-contact protein interaction
topologies suited to the role of these a/a-solenoid molecules
as facilitators of dynamic multi-subunit complexes. PR65/A,
for example, facilitates diverse phosphatase holoenzymes
involved in cell signaling and metabolism (16), while
importin-b serves distinct nuclear transport complexes that
engage a variety of cargos (17,18).
The emerging molecular view of huntingtin as a predomi-
nant HEAT/HEAT-like a-helical facilitator protein is sup-
ported by the results of studies of the full-length protein. For
example, endogenous full-length murine huntingtin exhibited
distinct subcellular epitope patterns, implying multiple alter-
nate conformations (8,19), and the ﬁrst circular dichroism
spectra of recombinant full-length human huntingtin denoted
a predominantly a-helical molecule (20). Moreover, while
the speciﬁc players in most cases remain to be identiﬁed, hun-
tingtin is thought to be multi-functional, participating in
diverse subcellular processes ranging from vesicle trafﬁcking
to energy metabolism and gene transcription (21).
As an approach to deﬁning huntingtin’s essential functional
molecular interactions in a mammalian system, we, and
others, are studying the consequences of targeted inactivation
of the murine HD gene. Huntingtin was initially shown to be
required in the extraembryonic tissue (22) to bypass a block
earlyinembryonicdevelopmentjustbeforehead-foldformation
(23–25). Our subsequent analysis of huntingtin null embryos
then revealed a constellation of other morphological and mol-
ecular phenotypes,including anterior streak and mesoderm pat-
terning deﬁcits, failure to properly silence growth (e.g. Nodal,
Fgf8) and transcription (e.g. Evx1, T) factor genes, that also
were reminiscent of embryos deﬁcient in polycomb repressive
complex 2 (PRC2), due to loss of core components Ezh2 (26),
Suz12(27)orEed(28),therebyimplyingapossibleintersection
of huntingtin with this epigenetic silencer (29).
Here we have investigated the a-solenoid view of the HD
protein, by determining the domain organization of a set of
full-length recombinant human huntingtins and by utilizing
these reagents, in conjunction with targeted mutations at the
murine HD locus that probe the endogenous protein, to
examine the speciﬁc hypothesis that huntingtin may assist
PRC2. The results of our analysis nominate huntingtin as a
novel a-solenoid stimulator of this multi-subunit histone H3
lysine 27 (H3K27) methyltransferase complex (30–33).
RESULTS
Recombinant full-length huntingtin hinged a-helical
domain structure
To determine whether full-length huntingtin might fulﬁll the
ﬂexible segmental organization of an a/a-solenoid protein,
we analyzed a set of full-length (.3144 residues) recombi-
nant human FLAG-tag huntingtins, with polyglutamine
tracts of 23, 32 or 43 residues. The proteins were expressed
in Sf9 insect cells from Baculovirus vectors, generated as
described in Materials and Methods, and, though large,
each recombinant protein was enriched by column chromato-
graphy from Sf9 insect cell extracts (Materials and Methods),
yielding a sharp elution peak (see Materials and Methods,
Supplementary Material, Fig. S1). As illustrated for
Q23-huntingtin (Supplementary Material, Fig. S1), the
enriched protein was full-length (350 kDa) and of high
purity, yielding a single Coomassie blue stained band that
immunoblot revealed was detected by N- and C-terminal hun-
tingtin antibodies.
Analysis of the recombinant protein by circular dichroism
produced spectra that conﬁrmed a predominant a-helical
structure (data not shown), as previously reported (20). To
investigate the protein’s overall domain organization,
FLAG-tag huntingtin was examined by negative stain electron
microscopy (EM). Analysis of about 10 000 interactively
selected Q23-huntingtin particles revealed 100 structurally
distinguishable classes (Supplementary Material, Fig. S2A),
illustrated by the representative class averages shown in
Figure 1A. These structural classes were also similar for
Q32 huntingtin and Q43 huntingtin (Supplementary Material,
Fig. S2B), revealing that the polyglutamine region did not
overtly alter huntingtin’s remarkable conformational variabil-
ity. Consistent with a ﬂexible segmental a-helical domain
organization, limited tryptic digestion of the recombinant
protein readily yielded two large domains (150 kDa and
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(Supplementary Material, Tables S1 and S2) located a major
accessible hinge region between residues 1184–1254.
Notably, the smaller fragments produced by continued diges-
tion (Fig. 1B) revealed that the extreme N-terminus, with its
polyglutamine segment, was buried within the 150 kDa
domain, on an initially inaccessible 60 kDa subdomain.
This was consistent with the results of CHOP, for structural
domains (34,35), which predicted residues 124–971 in a
super-helical architecture, with signiﬁcant similarity
(2.5e
220) to PR65/A (PDB I.D. 1b3u).
Multiple sequence alignment of eight representative chor-
date huntingtins (sea squirt to human) (see Materials and
Methods), summarized in Figure 1C and the phylogram in
Figure 1D, revealed that the conservation of the unstructured
hinge segment and pattern of a-helical structure were con-
served through 500 million years of evolution, strongly
implying that huntingtin’s overall modular organization
and conformational ﬂexibility are critical for its biological
function.
Impaired PRC2 function in the absence of huntingtin
The hypothesis that huntingtin may facilitate PRC2 was ﬁrst
explored in vivo by examining huntingtin null Hdh
ex4/5 homo-
zygote embryos and cultured EBs for molecular epigenetic
phenotypes reported in PRC2-deﬁcient embryos (26–28,36).
Though Hdh
ex4/5 homozygote embryos at embryonic stage
E7.5 have previously been shown to properly localize stage-
appropriate markers such as Otx2, Hnf3b and Hesx1 (29),
the results of whole mount in situ hybridization, in
Figure 2A, revealed that huntingtin null embryos failed to
properly repress PRC2 regulated Hox gene expression, as evi-
denced by ectopic Hoxb1, Hoxb2 and Hoxb9 mRNA. More-
over, female huntingtin null embryos exhibited decreased
differentiation of trophoblast giant cells, marked by PL-1
mRNA expression, which normally requires proper obligatory
silencing of the paternally inherited X chromosome. Indeed, in
the absence of huntingtin, female embryos inheriting a pater-
nally transmitted X chromosome marked by a GFP-transgene,
displayed inappropriate reactivation of GFP-signal in cells of
Figure 1. Huntingtin conformational ﬂexibility and domain organization. (A) Representative area of an electron micrograph of negatively stained FLAG-Q23
huntingtin (scale bar 50 nm) (left) and representative class averages (side length of panels is 28.8 nm) (right) showing the structural variability of huntingtin. (B)
Timed proteolysis of Q23 FLAG-huntingtin (Htt350) with trypsin (0, 5, 10, 20 min) yielded two major Coomassie Blue stained products at 150 kDa (Htt150)
and 200 kDa (Htt200) (left), though immunoblot probed with anti-FLAG detected the 150 kDa fragment and a smaller 60 kDa product (right). (C) Sche-
matic of human huntingtin (blue bar), with FLAG-tag (green) and locations of Htt150 and Htt250 mass spectrometry peptides (Supplementary Material, Tables
S1 and S2) and major trypsin cleavage site (asterisk). Below this, huntingtin (open line) is depicted with the polyglutamine tract (black block) and amino acid
coordinates (above), NORSp predicted disordered regions (light blue), matching the predictions of PROF where pHsec, pEsec and pLsec represent the probability
(1 ¼ high, 0 ¼ low) for helix (red), strand (blue) and neither helix nor strand (green). Below this, compressed multiple sequence alignment of huntingtin from
human and seven chordates with increasing intensity of blue shading for residues identical in 4 to 8 organisms and physico-chemical properties (from Jalview)
conserved for each amino acid position, from dark brown (least) to bright yellow (most), with height corresponding to increasing conservation. (D) Phylogram
based upon alignment of huntingtin homologues for the eight representative chordates, with branch lengths proportional to the inferred evolutionary change.
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inactivation in the embryro proper appeared to be normal.
Investigation of histone H3K27 methylation in Hdh
ex4/5 null
EBs, developing in cell culture from embryonic stem cells,
demonstrated that huntingtin was required for efﬁcient
re-establishment of global tri-methylated histone H3K27.
The level of tri-methylated histone H3K27 was decreased at
day 2 (data not shown) and day 4, as illustrated by immunos-
taining and immunoblot analysis, in Figure 2B, though was
normalized by days 6–11 (Supplementary Material,
Fig. S3A). Notably, global levels of di-methylated histone
H3K27 were not altered in huntingtin null EBs (Supplemen-
tary Material, Fig. S3B), indicating that lack of huntingtin
speciﬁcally affected H3K27 tri-methylation.
The phenotypes that indicated impaired PRC2 function in
huntingtin-null embryos were less severe than complete loss
of PRC2 methyltransferase activity, due to lack of the Ezh2
catalytic subunit, and appeared milder than phenotypes
due to loss of Eed. This is consistent with a role for
huntingtin, not as a core PRC2 component, but as an essential,
potentially dynamic, facilitator of PRC2 activity during devel-
opment.
Figure 2. Huntingtin stimulated PRC2 during development. (A) Whole mount in situ hybridization Hoxb1, Hoxb2, Hoxb9 mRNA expression in E7.5 Hdh
ex/4/5/
Hdh
ex/4/5 (KO) huntingtin null embryos was not properly silenced and restricted to the posterior, as observed for wild-type Hdh
þ/Hdh
þ (WT) embryos (top).
Decreased placental lactogen (PL-1) mRNA signal (purple) in bisected decidua revealed fewer giant trophoblast cells in female embryos lacking huntingtin
(KO), compared with null male (KO) or wild-type (WT) embryos of either gender (bottom). Female embryos, at the indicated developmental stages (ectopla-
cental cone, Reichert’s membrane removed), show aberrant Xp GFP-transgene reactivation in the Hdh
ex/4/5/Hdh
ex/4/5 (KO) extraembryonic tissue (Exem), com-
pared with Hdh
þ/Hdh
þ (WT) tissue, while random inactivation in the embryo proper (Em) appeared normal (right). (B) Confocal images of immunostained
sections of day 4 Hdh
þ/Hdh
þ (WT) and Hdh
ex/4/5/Hdh
ex/4/5 (KO) huntingtin null EBs revealed decreased histone H3K27me3 signal in the latter, whereas
knock-in Hdh
þ/Hdh
Q111 (KI) EBs, expressing huntingtin with a 111 residue polyglutamine segment exhibit increased histone H3K27me3 signal. Immunoblot
of nuclear extracts and plot of histone H3K27me3/H3 band intensity ratio, normalized to wild-type (white bar), conﬁrmed signiﬁcantly (P , 0.016) decreased
histone H3K27me3 in Hdh
ex/4/5/Hdh
ex/4/5 (KO) extracts (black bar) and signiﬁcantly (P , 0.044) increased histone H3K27me3 in knock-in Hdh
þ/Hdh
Q111 (KI)
extract (grey bar), compared with wild-type (n ¼ 4).
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tri-methyltransferase activity
Developing day 4 EBs were chosen as a system amenable to
biochemical analysis, to evaluate the possibility that full-
length huntingtin might intersect with PRC2 in the nucleus.
Full-length huntingtin was detected by immunoblot analysis
in nuclear, as well as cytoplasmic extracts (Supplementary
Material, Fig. S3C), and antibody reagent AP194, which
immunostained nuclear though not cytoplasmic conformations
of full-length huntingtin (8), revealed huntingtin in the nuclei
of cells in all three germ-layers, with Ezh2-stain, especially in
the outermost endodermal cells (Fig. 3A). Furthermore, the
results of analysis of nuclear extracts by gel ﬁltration chrom-
atography demonstrated that full-length huntingtin was
co-eluted with PRC2 subunits Ezh2 and Suz12 (Supplemen-
tary Material, Fig. S3D). Analysis by co-immunoprecipitation,
with speciﬁc antibody reagents, yielded a proportion of full-
length huntingtin, with Ezh2 and Suz12, as revealed by immu-
noblot analysis of the precipitated proteins shown in
Figure 3B. In addition, as summarized in Figure 3C, chromatin
immunoprecipitation (ChIP), with anti-huntingtin or anti-
histone H3K27me3, enriched Hoxb9 sequences from wild-
type, though not from huntingtin null day 4 EB nuclei,
thereby placing huntingtin at Hoxb9 chromatin in wild-type
cells and supporting a functional role for huntingtin in stimu-
lating histone H3K27 trimethylation.
This interpretation was conﬁrmed by the results of in vitro
experiments, to determine whether recombinant full-length
human huntingtin would interact with and alter the histone
H3K27methyltransferaseactivityofreconstitutedPRC2inapre-
viously reported in vitro assay (30–33) (see Materials and
Methods).Asshownintheimmunoblot inFigure4A,full-length
FLAG-tag Q23 huntingtin added to recombinant PRC2 was
co-immunoprecipitated with Ezh2 and Suz12, and, as illustrated
in Figure 4B, the recombinant protein signiﬁcantly increased
PRC2-speciﬁc histone H3K27 methylation, as judged by the
intensity of bands of incorporated tritium. The stimulatory
effect of full-length huntingtin, compared with reactions
without huntingtin or with control peptides, was observed over
a range of huntingtin (Supplementary Material, Fig. S4A) and
nucleosomal array (Supplementary Material, Fig. S4B) concen-
trations. Furthermore, consistent with the ﬁnding that huntingtin
was needed to stimulate tri- but not di-methylation of histone
H3K27 in vivo (Fig. 2B, Supplementary Material, Fig. S3B),
the results of immunoblot analysis of the in vitro PRC2 reaction
products demonstrated that recombinant huntingtin speciﬁcally
enhanced histone H3K27 tri-methylation but not di-methylation
(Supplementary Material, Fig. S4C).
The polyglutamine region modulated huntingtin PRC2
stimulation
Functional interactions involving globular proteins are typi-
cally validated by structure–function experiments that entail
targeted disruption of a single point-to-point protein inter-
action motif. However, consistent with previous evidence of
Figure 3. Huntingtin associated with PRC2 in the nucleus. (A) Fluorescent microscope images of an immunostained section of a day 4 Hdh
þ/Hdh
þ wild-type
(WT) EB, demonstrating the nuclear conformation of huntingtin (Htt), detected by AP194 antibody (8), and anti-Ezh2-signal in DAPI-stained nuclei (merge). (B)
Immunoblot showing co-immunoprecipitation of Ezh2 and Suz12 with huntingtin (Htt), from nuclear extracts of day 4 Hdh
þ/Hdh
þ (WT) EBs. (C) Plot of the
results of chromatin immunoprecipitation analysis of Hoxb9, demonstrating enrichment of huntingtin (Htt) and trimethylated histone H3K27 (H3K27me3) in day
4 Hdh
þ/Hdh
þ wild-type (WT) EBs, that is not apparent in the absence of huntingtin in Hdh
ex4/5/Hdh
ex4/5 (KO) EBs, but is increased in Hdh
þ/Hdh
Q111 knock-in
(KI) EBs, expressing 111-glutamine huntingtin (n ¼ 3; anti-Htt KO versus WT P , 0.0004; anti-histone H3K27me3 KO versus WT P , 0.0037; anti-Htt KI
versus WT P , 0.4267; anti-histone H3K27me3 KI versus WT P , 0.0157).
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recombinant huntingtin revealed a ﬂexible, non-globular
HEAT repeat a-helical domain organization (Fig. 1, Sup-
plementary Material, Fig. S2). For other HEAT solenoids,
protein-interaction entailed dramatic conformational switches
and complex multiple points of contact along the idiosyncratic
contours formed by HEAT repeat packing, not accurately
mapped by the methods that determine the sites of
docking-interactions between globular proteins (37).
Therefore, in the absence of detailed knowledge of hunting-
tin’s likely complex interactions with PRC2, and perhaps its
chromatin substrate, we assessed the potential impact of hun-
tingtin’s only known naturally occurring functional poly-
morphism. The polyglutamine region has been shown to
subtly but signiﬁcantly modulate the consequences of
endogenous full-length murine and human huntingtin in vivo
(5,6). Moreover, our analysis of recombinant full-length hun-
tingtins demonstrated that the polymorphism, even into the
expanded HD range, did not overtly alter the protein’s
overall structure (Supplementary Material, Fig. S2), consistent
with the ﬁnding that this modulatory region did not impair (38)
and indeed was not needed for huntingtin’s early developmen-
tal activity (5).
The potential effect of the polyglutamine region on PRC2
activity was ﬁrst assessed by analysis of day 4 EBs expressing
endogenous murine huntingtin with 111-glutamines, from the
previously described Hdh
Q111 knock-in allele (19,39). Com-
pared with wild-type EBs, and in contrast to huntingtin-null
EBs, the cells of Hdh
Q111/Q7 EBs exhibited elevated levels
of tri-methylated histone H3K27, by immunostaining and
immunoblot analysis, as shown in Figure 2B, though not
di-methylated H3K27 (Supplementary Material, Fig. S3B).
Moreover, ChIP analysis revealed increased enrichment of
huntingtin and tri-methylated histone H3K27 at Hoxb9,a s
summarized in Figure 3C. Consistent with these ﬁndings, as
shown in Figure 4C, in the in vitro assay with reconstituted
PRC2, full-length recombinant human proteins with polygluta-
mine segments longer than 23-residues (32- and 43-residues)
progressively increased huntingtin stimulation of histone
H3K27 methylation. Thus, in both the cell-based and the
molecularly-deﬁned structure–function experiments, the
impact of the polyglutamine modulatory region conﬁrmed
huntingtin’s role in facilitating the PRC2 histone H3K27
methyltransferase complex.
DISCUSSION
The expansion of the polymorphic polyglutamine region in the
huntingtin HEAT repeat protein is the root genetic cause of
HD pathogenesis. Despite this compelling reason, and
though this ancient protein is of interest because it is the
founding member of a growing class of HEAT repeat proteins,
huntingtin’s molecular organization and function have
attracted relatively little attention. The results of our genetic
structure–function experiments extend the single report of
native huntingtin’s predominant a-helical nature (20), by
demonstrating features consistent with a ﬂexible a-solenoid
organization and by providing strong empirical support for
huntingtin as a dynamic facilitator of at least one multi-
functional macromolecular complex, the PRC2 methyltrans-
ferase.
Probing the structural organization of full-length native
recombinant human huntingtin by circular dichroism spec-
troscopy, we conﬁrmed the protein’s previously reported pre-
dominant a-helical nature (20). However, in contrast to that
report, our puriﬁcation strategy yielded a sharp chromato-
graphic peak comprising only full-length huntingtin, without
the reported 220 kDa piece of huntingtin (starting at
residue 622), which we speculate may have arisen from pro-
teolysis of partially denatured protein produced by the
harsher puriﬁcation conditions utilized in that study. Limited
proteolysis of the native full-length recombinant huntingtin
initially yielded two major products, an N-terminal
Figure 4. Huntingtin stimulated recombinant PRC2 in vitro.( A) Immunoblot showing co-immunoprecipitation of FLAG-huntingtin with recombinant Ezh2 and
Suz12 members of reconstituted PRC2 to which huntingtin (Htt) was added (þ) or was not added (2). (B) Autoradiogram of bands of
3H-methyl histone H3
produced by reconstituted PRC2, and below the plot of the quantiﬁed band intensities, demonstrating that addition of 40 nM recombinant Q23 huntingtin (Htt),
but not bovine serum albumin (BSA), or tag-peptide (Tag peptide), signiﬁcantly stimulated PRC2 activity. (n ¼ 3;  P , 0.05). (C) Autoradiogram showing
bands of
3H-methyl histone H3 produced by reconstituted PRC2 in the absence (2) and presence of 2 nM recombinant huntingtins, with different polyglutamine
sizes, and below a plot of quantiﬁed band intensities, relative to baseline PRC2 activity, demonstrating a progressive increase in huntingtin’s stimulation of PRC2
as polyglutamine size is increased (n ¼ 3; Q43Htt or Q32 versus no Htt  P , 0.017; Q43Htt versus Q23Htt   P , 0.045).
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C-terminal segment (starting at residue 1254), implying a
domain organization comprising two large nearly equal sized
a-helical arms, separated by an accessible hinge region. Con-
tinued digestion of these domains yielded additional bands,
including an 60 kDa N-terminal fragment bearing the poly-
glutamine region that implied cleavage within an unstructured
region located at residue 500. Thus, though it may be sus-
ceptible to proteolytic cleavage when huntingtin is denatured,
this sub-domain was buried within the 150 kDa N-terminal
arm of the native protein, likely because this domain may
assume a super-helical structure resembling the PR65/A
a-solenoid (PDB I.D. 1b3u).
The segmental a-helical domain organization and the con-
formational ﬂexibility of full-length huntingtin, revealed by
negative stain EM, are general structural features expected
of a predominant HEAT repeat a/a-solenoid protein.
However, high-resolution analysis will be needed to prove
the continuous helical structure of the molecule. Indeed,
though the elongated and often curved shapes formed by
stacking of adjacent HEAT and HEAT-like repeats are
similar for different HEAT repeat proteins, the precise con-
tours are determined by the amino acid sequences of these
degenerate structural elements. To date, crystal structures for
the ﬁrst 60 amino acids of huntingtin (encoded by exon 1)
have been analyzed, directly demonstrating the a-helical sec-
ondary structure of the ﬁrst 17 amino acids, the structural
variability of the abutting 17 residue polyglutamine segment
and helical arrangement of the adjacent polyproline rich
segment (40). Knowledge of the domain organization of
native huntingtin, which was not accurately predicted using
various pieces of the protein (41), should now spur efforts to
determine the higher-order structure of the functional protein.
In support of huntingtin’s role as a facilitator, implied by its
predominant HEAT domain structure, the lack of huntingtin
led to impaired PRC2 epigenetic gene and chromatin silencing
function in embryos and impaired reestablishment of global
histone H3K27 tri-methylation in developing EBs, whereas
full-length recombinant human huntingtin speciﬁcally stimu-
lated the tri-methyltransferase activity of reconstituted
PRC2. Furthermore, as implied by co-immunoprecipitation
of the full-length endogenous and recombinant proteins with
core PRC2 members, huntingtin’s direct role in stimulating
PRC2, in vivo and in vitro, was conﬁrmed by the progressive
effect of huntingtin’s polymorphic polyglutamine region, pre-
viously recognized as a modulatory segment of full-length
endogenous murine (5) and human (6) huntingtin.
Though our data reveal that huntingtin’s role in facilitating
PRC2 tri-methyltransferase activity is important for normal
murine embryonic development, the timing and duration of
this interaction, as well as the subset of PRC2-target genes
that may, like Hoxb9, be modulated, are areas that remain to
be investigated. Though it is not clear exactly how huntingtin
may interact with PRC2 and/or its nucleosomal histone sub-
strate, it is unlikely to stimulate PRC2 in the same manner
as PHF1, a recently reported globular PRC2 accessory
protein that is thought to contact the Ezh2 catalytic subunit
via its PHD ﬁnger domains (42,43). Indeed, as discussed
earlier, full-length huntingtin’s proposed a-helical solenoid
structure promises to offer a novel mode of PRC2 regulation.
It seems reasonable, from the striking alternate sub-cellular
epitope patterns of the full-length endogenous protein, that
this will entail dramatic conformational switches and
complex contacts along the topological contours formed by
stacking of the protein’s adjacent HEAT/HEAT-like repeats,
as reported for other predominant a-solenoid proteins (16–
18). The availability of a system for purifying native full-
length recombinant huntingtin, and empirical knowledge of
its domain organization, should now enable high-resolution
structural studies to determine the details of huntingtin’s func-
tional molecular interactions with PRC2/chromatin, including
the potential structural role of the modulatory polyglutamine
region.
In summary, the proposal that full-length huntingtin com-
prises a large hinged a-helical solenoid, which serves as a
facilitator of the PRC2 complex, now provides a nuanced
view of the molecule and its polymorphic polyglutamine
region, thereby setting the stage for deﬁning other functional
complexes that full-length huntingtin may assist. Furthermore,
it provides novel starting points for understanding the in vivo
regulation of mammalian PRC2 and suggests that enhanced
activity of this epigenetic regulator merits investigation as a
potential contributor to HD neurodegeneration.
MATERIALS AND METHODS
Human FLAG-huntingtin insect vector expression clones
pFASTBAC1 vector (Invitrogen), with a FLAG-tag sequence
adjacent to the unique BamHI site, was cleaved and a 10 kb
EagI–BssHII fragment encoding human huntingtin (23 gluta-
mines) (Genbank accession number L12392) was inserted.
pFASTFLAGHttQ23 encodes FLAG-tag-KGERGAASRPEA
SGDCRAGRETA polypeptide in frame with the 3144 amino
acid huntingtin sequence (FLAG-Q23 huntingtin). pA
LHDQ32, pALHDQ43 encoding full-length human FLA
G-Q32 and -Q43 huntingtins, respectively, were generated in
pFASTBAC1, modiﬁed to insert a polylinker containing
FLAG, 6X histidine tag sequence and TEV protease recog-
nition site, between the unique BamHI–KpnI sites. NcoI–XhoI
HD cDNA fragments, encoding huntingtin amino acids 1–171
with different size polyglutamine tracts (Q32, Q43) (10,44)
were inserted between the unique NcoI and XhoI sites, fol-
lowed by in frame insertion of a 9046 bp human HD cDNA
XhoI–SacII fragment, encoding human amino acids
172–3144 (10,44). All clones were veriﬁed by full DNA
sequence analysis.
FLAG-huntingtin puriﬁcation
FLAG-tag huntingtin was expressed from pFAST-
FLAGHttQ23 in the Bac-to-Bac Baculovirus Expression
system (Invitrogen). The Sf9 cell lysate, generated by
freeze/thawing in buffer A (50 mM Tris–HCl pH 8.0,
500 mM NaCl, 5% glycerol and complete protease inhibitors),
was spun at 15 000 rpm (2 h). The supernatant was incubated
with M2 anti-FLAG beads (Sigma) (2 h, 48C).
FLAG-huntingtin was eluted with buffer (50 mM Tris–HCl
pH 8.0, 300 mM NaCl, 5% glycerol) containing 0.4 mg/ml
FLAG peptide and loaded onto a calibrated Superose 6TM
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150 mM NaCl. FLAG-huntingtin eluted discretely and was
estimated to be at least 90% pure by Coomassie staining.
Recombinant FLAG-Q32 and -Q43 huntingtins were puriﬁed
in exactly the same manner. Comparisons of huntingtins
with different polyglutamine sizes were performed with an
equal amount of each protein, as judged by Bio-Rad DC
protein assay and R-250 Coomassie blue staining of bands
on 6% SDS–PAGE, which controlled for potential differences
in purity and conﬁrmed equal amounts of protein. The
molarity for all huntingtins was calculated using a molecular
weight of 350 kDa deduced from the human cDNA sequence
(GenBank accession number L12392).
EM and image processing
Samples were prepared by negative staining with 0.75% (w/v)
uranyl formate as described previously (45). Images were col-
lected with a Tecnai T12 electron microscope (FEI, Hillsboro,
OR) equipped with an LaB6 ﬁlament and operated at an accel-
eration voltage of 120 kV. Images were recorded on imaging
plates at a nominal magniﬁcation of 67 000x and a defocus
value of 21.5 mm using low-dose procedures. Imaging
plates were read out with a Ditabis micron imaging plate
scanner (DITABIS Digital Biomedical Imaging System AG,
Pforzheim, Germany) using a step size of 15 mm, a gain
setting of 20 000 and a laser power setting of 30%. 2   2
pixels were averaged to yield a pixel size of 4.5 A ˚ on the
specimen level. Using BOXER display (EMAN software
package) (46), 10 061 particles interactively selected from
53 images were windowed into 64   64 pixel images using
the SPIDER software package (47), which was also used for
all other image processing procedures. The particles were rota-
tionally and translationally aligned and subjected to 10 cycles
of multireference alignment, with K-means classiﬁcation, spe-
cifying 100 output classes, after each round. The references
used for the ﬁrst multi-reference alignment were randomly
chosen from the raw images.
Huntingtin structure prediction and evolutionary
conservation
Human huntingtin amino acid sequence (Homo sapiens;
NP_002102) was analyzed for predicted secondary structure
using: NORSp (48) and PROF (Proﬁle network prediction
HeiDelberg) (49) from the PredictProtein server (http://www.
predictprotein.org/) (50). Huntingtin orthologues for the
multiple sequence alignments: dog (Canis familiaris;
XP_536221), mouse (Mus musculus; AAA89100), opossum
(Monodelphis domestica; XP_001364862), chicken (Gallus
gallus; XP_420822), zebraﬁsh (Danio rerio; NP_571093); lan-
celet (Branchiostoma ﬂoridae; ABP04240) and sea squirt
(Ciona intestinalis; NP_001119700), were aligned using Clus-
talW2 (European Bioinformatics Institute: http://www.ebi.ac
.uk/Tools/clustalw2/) (51) and viewed and edited using
Jalview 2.3 (http://www.jalview.org/) (52). The initial align-
ment used the ClustalW2 server default parameters (except
iteration:tree and numiter:8). For secondary structure predic-
tions, ‘extra’ sequences of greater than ﬁve amino acids rela-
tive to human huntingtin, were deleted from orthologues
(apparent insertions of 23, 50 and 24 residues in zebraﬁsh, lan-
celet and sea squirt at human 1051, 10 and 20 amino acids in
sea squirt and lancelet at human 2145, 11 residues in lancelet
at human 2195 and 26 residues in sea squirt at human 2642).
After re-alignment, gaps of ,5 residues in the human
sequence were removed from any of the other sequences.
The ﬁnal ‘no-gap’ set was re-aligned producing the ﬁnal mul-
tiple alignment. This was exported as an image ﬁle (PNG
format) and compressed in PowerPoint. Jar ﬁles of the initial
and ﬁnal alignments are available on request. The physico-
chemical properties conserved for each amino acid position
were calculated in Jalview (53). CHOP (34,35) predicted ter-
tiary structure, with searches of the CATH protein structure
classiﬁcation database, to identify potential structural domain
homologues. FoldIndex was also used to predict unfolded




ex4/5 embryos were obtained from
timed matings of Hdh
ex4/5/Hdh
þ heterozygote mice and geno-
typed by PCR assay as described (23). The day of plug was
deﬁned as E0.5. GFP X chromosome transgene mice were
from The Jackson Laboratory (strain 003116).
In situ hybridization
Dissected embryos and decidua were ﬁxed in 4% paraformal-
dehyde at 48C brought through a sucrose gradient (15%
sucrose, 30% sucrose), embedded in OCT and sectioned at
10 mm. RNA in situ hybridizations, performed as reported
(55), were with antisense PL-1 probe synthesized with Sp6
and anti-sense Hox probes generated as described previously
(56).
Embryonic stem cell and EB tissue culture
Wild-type and huntingitn null Hdh
ex4/5/Hdh
ex4/5 ES cells,
reported previously (23), as well as Hdh CAG knock-in
Hdh
þ/Hdh
Q111 ES cells (19) were cultured at 378Ci n5 %
CO2 in ESCM medium [DMEM, 15% FBS, penicillin strepto-
mycin, glutamine, non-essential amino acids, 0.7%
b-mercaptoethanol, 10
6 U/l ESGRO (Chemicon-Millipore)].
EB formation was in ESCM without ESGRO (LIF) on
untreated polystyrene plates.
EB immunocytochemistry
EBs were ﬁxed, embedded and sectioned as earlier. PBS
washed sections, blocked with 10% goat serum in PBST
(0.1% Triton) were incubated with primary antibody (over-
night, 48C) in PBST/0.1% goat serum. Secondary antibody
was in PBST/0.1% goat serum. Mounting was in Vectashield
containing DAPI (Vector labs). Primary antibodies: tri-methyl
histone H3K27 (Upstate Biotechnology, Inc.), di-methyl
histone H3K27 (Abcam), Ezh2 (BD Transduction labs) and
huntingtin AP194 (Dr A. Sharp).
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Proteins were transferred from SDS–PAGE to nitrocellulose
membrane (Schleicher & Schuell), blocked in 10% non-fat
powered milk in TBS-T (50 mM Tris–HCl, 150 mM NaCl,
pH 7.4, 0.1% Tween 20). Primary antibody incubation was
overnight (48C). Incubation with horseradish peroxidase-
conjugated secondary antibody (Amersham Pharmacia
Biotech) was 1 h (room temperature). Signal was detected
by ECL chemiluminiscence (PerkinElmer) with autoradio-
graphic ﬁlm (Hyperﬁlm ECL; Amersham Bioscience).
Additional primary antibodies were: huntingtin mAb2166
(Chemicon-Millipore), Suz12 (Upstate Biotechnology, Inc.),
polyglutamine mAb 1F8 (10), histone H3 (Abcam),
a-tubulin (Sigma) and ﬁbrillarin (Santa Cruz Biotechnology,
Inc.).
Subcellular fractionation
Subcellular fractions were prepared as reported (57). Washed
cell pellets were homogenized in buffer [20 mM HEPES, pH
7.0, 1.5 mM MgCl2,1 0m M KCl, 0.5 mM DTT, 1 mM PMSF
and complete protease inhibitors (Roche Applied Science)],
using 10 strokes with a glass Dounce pestle. Supernatant
from the 1000 g spin (10 min, 48C) was the cytoplasmic frac-
tion. Nuclear extract was generated from the pellet by resus-
pending in ELB buffer (250 mM NaCl, 0.1% NP-40, 50 mM
HEPES, pH 7.0, 5 mM EDTA, 0.5 mM DTT, 1 mom PMSF,
and complete protease inhibitors), sonicating (3 times, 10 s
pulses), and saving the supernatant of a 14 000 g spin
(10 min, 48C). Protein concentration for this experiment and
all others was measured with Bio-Rad DC (Detergent Compa-
tible) (Bio-Rad).
Immunoprecipitation
Immunoprecipitation assays entailed: (i) incubation (RT for
2 h) of nuclear lysate (500 mg) and mAB2166 or control IgG
from mouse serum (Sigma) or (ii) incubation (at 378C for
2 h) of puriﬁed PRC2 complex (2.5 mg) and FLAG-huntingtin
(1.25 mg) with mAb2166 or anti-Ezh2. Protein A Sepharose
beads (Roche) were added for 1 h (48C), washed (8 times)
in ELB plus (250 mM NaCl, 0.1% NP-40, 50 mM HEPES,
5m M EDTA) and boiled for 5 min in reducing SDS sample
buffer to remove the complexes from the beads.
Chromatin immunoprecipitation and quantitative PCR
ChIP assays were performed using the Agilent mammalian
ChIP-on-chip protocol as speciﬁed by the manufacturer
(Agilent Technologies), except for huntingtin immunoprecipi-
tation, where mAb 2166 was incubated with chromatin for 2 h
at room temperature, to reduce non-speciﬁc background. Anti-
bodies were anti-histone H3K27me3 (Abcam ab6002) anti-
body, anti-huntingtin (Millipore mAb 2166) and control IgG
(Sigma).
Puriﬁed input of chromatin (25 ng) or immunoprecipitated
(IP) DNA (100 ng) from ChIP were used as a template in
50 ml reactions containing 25 ml of 2X SYBR Green Master
Mix (Applied Biosystems) and 10 pmol of each primer. PCR
reactions were performed with iCycler thermal cycler
(Bio-Rad) and as follows: 50 cycles of 958C for 15 s, 548C
for 15 s and 728C for 15 s. All PCRs were performed in tripli-
cate and threshold amplication cycle numbers (Tc) using
iCycler software were used to calculate IP DNA quantities
as percentages of corresponding inputs using the following
equation: IP DNA as a percentage of input ¼ 2
(DTc)   100,
DTc ¼ input DNA Tc 2 IP DNA Tc. Statistics were analyzed
using Student’s t-test. Hox B9 promoter primer sequences for
q-PCR were; left primer 50-TGGCCTTAGGCAGGCTAT
AA-30 and right primer 50-GGCTCTTCCCTTGATCCTTT-30.
Acid precipitation of histones
Cells were lysed in 5–10 volumes of lysis buffer (10 mM
HEPES, pH 7.9, 1.5 mM MgCl2,1 0 m M KCl), hydrochloric
acid was added to 0.2 M ﬁnal concentration, incubated
(30 min, ice) and the extract spun at 11 000 g (10 min, 48C).
The supernatant was dialyzed twice against 20 volumes of
0.1 M acetic acid (1 h) and then dialyzed three times against
20 volumes of water. The acid precipitated proteins were
loaded on 12% SDS–PAGE gel for immunoblot.
Size exclusion chromatography fractionation
Day 4 EB nuclear lysates were subjected to size exclusion
chromatography on a pre-calibrated (with size standards
listed in legend) Superose-6TM HR 16/60 column, equilibrated
with 20 mM HEPES pH 7.5 containing 1 mM MgCl2, 150 mM
NaCl and 0.5 mM DTT. Fractions (1.5 ml) were collected.
Blue Dextran was used as void volume marker and was
eluted at fraction number 26.
Cell-free assay for PRC2 histone H3 methyltransferase
activity
Pre-assembled human PRC2 complex, FLAG-EED, EZH2,
SUZ12 and RbAp48 proteins, was puriﬁed, from Sf9 cells
co-infected with the cognate pFastBac1 constructs, by M2
anti-FLAG bead afﬁnity column and Superose 6TM gel ﬁl-
tration chromatography (equilibrated with 50 mM Tris–HCl
pH 8.0, 150 mM NaCl, 10% glycerol). The molarity was calcu-
lated using a MW of 270 kDa, which assumes one copy of
each subunit per complex. The G5E4 nucleosomal array was
assembled with Xenopus recombinant histones and G5E4
DNA fragments containing 12 nucleosomal positioning
sequences, as reported (58,59).
The reconstituted PRC2 activity assay was optimized from a
previous method (33). A reaction mixture of 15 ml comprised:
100 mM Tris–HCl pH 8.3, 1 mM DTT, 0.5 mM
3H-SAM, 4 nM
PRC2 and 0.025–0.1 mM nucleosomal array. Incubations were
at 308C for 30 min, unless otherwise stated. For comparison of
huntingtin’s with different polyglutamine tracts, reactions
were performed at 308C with 2 nM of each protein for
30 min. Sample buffer was added to stop the reactions,
which were subjected to 12% SDS–PAGE, transferred to
Immobilon-P
SQ membrane (Millipore), and exposed to phos-
phorimager screen. The
3H-H3K27 bands detected with
Typhoon (ImageQuant as software, GE Healthcare Life
Science) were quantiﬁed with Quantity One software
Human Molecular Genetics, 2010, Vol. 19, No. 4 581(Bio-Rad). For the scaled up cold assay, a 60 ml reaction
included: 100 mM Tris–HCl pH 8.3, 1 mM DTT, 2 mM SAM,
50 nM PRC2 and 0.1 mM nucleosomal array, with or without
40 nM FLAG-huntingtin (4 h, 308C). Bands on immunoblots
were scanned with GS-800 Calibrated Densitometer
(Bio-Rad). All values were expressed as mean+1 SD. The
statistical signiﬁcance was determined by Student’s t-test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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